阴性淋巴结数目在实体肿瘤预后中的价值

Prognostic Value of Negative Lymph Nodes Count in Solid Tumors

摘要: 术后病理分期系统（pTNM）已成为全球范围内多种肿瘤治疗策略选择和预后评估的重要参考依据，是多种实体肿瘤预后强有力的预测指标，但pTNM分期相同的肿瘤患者预后仍有差异。近年来有研究证实阴性淋巴结数目（NLNC）与多种实体肿瘤预后有关，随着清扫NLNC的增加可以改善患者的预后，且NLNC可以减少分期迁移，其有望作为pTNM分期系统的补充。本文就NLNC在实体肿瘤预后中的价值进行综述。

Abstract: The postoperative pathological staging system (pTNM) has become an important reference for the selection of various tumor treatment strategies and prognosis evaluation at a global scale, and is a powerful predictor of the prognosis of a variety of solid tumors, but the prognosis is still different in patients with the same pTNM staging. In recent years, studies have confirmed that the negative lymph nodes count (NLNC) is related to the prognosis of a variety of solid tumors. Higher NLNC can improve the prognosis of cancer patients, and NLNC can reduce staging migration, which is expected to be a supplement to the pTNM staging system. This article reviews the value of NLNC in the prognosis of solid tumors.